Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (691-700 of 818) with videos related to

Pageof 82
Sort By:
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.
Genetics|September 9, 2000
Retrotransposon evolution in diverse plant genomesT Langdon, C Seago, M Mende, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants GroupM A Pfaller, R N Jones, G V Doern, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinR N Jones, P C Fuchs, H M Sommers, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1982
Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophyJ L Swain, R L Sabina, R B Peyton, et al.
Journal of Clinical Microbiology|August 1, 1997
Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosaG V Doern, A B Brueggemann, R Perla, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centersH S Sader, R N Jones, S D Allen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 12, 2005
Identification of a novel cephalosporinase (DHA-3) in Klebsiella pneumoniae isolated in TaiwanL-T Wu, S-W Hung, Y-C Chuang, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheaeR N Jones, M E Erwin, J A Washington, et al.
Pageof 82

Showing results (691-700 of 818) with videos related to

Sort By:
Pageof 82
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.
Genetics|September 9, 2000
Retrotransposon evolution in diverse plant genomesT Langdon, C Seago, M Mende, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants GroupM A Pfaller, R N Jones, G V Doern, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinR N Jones, P C Fuchs, H M Sommers, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1982
Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophyJ L Swain, R L Sabina, R B Peyton, et al.
Journal of Clinical Microbiology|August 1, 1997
Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosaG V Doern, A B Brueggemann, R Perla, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centersH S Sader, R N Jones, S D Allen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 12, 2005
Identification of a novel cephalosporinase (DHA-3) in Klebsiella pneumoniae isolated in TaiwanL-T Wu, S-W Hung, Y-C Chuang, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheaeR N Jones, M E Erwin, J A Washington, et al.
Pageof 82